Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Eastham
    Eastham
  5. Jarnagin
    Jarnagin
  6. Reuter
    Reuter
  7. D'Angelica
    D'Angelica
  8. Kingham
    Kingham
  9. Ladanyi
    Ladanyi
  10. Scher
    Scher

Groups

  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)
  7. Epidemiology and Biostatistics (685)
  8. Sloan Kettering Institute Faculty (612)
  9. Department of Pathology and Laboratory Medicine (586)
  10. GSK Faculty (582)
Search Within
Formats
  1. Journal Article (3901)
  2. Meeting Abstract (1049)
  3. Editorial (165)
  4. Review (132)
  5. Correspondence (113)
  6. Guidelines (79)
  7. Research Letter (29)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2049)
  2. Department of Medicine (1334)
  3. Urology (1158)
  4. Solid Tumor Oncology Division (829)
  5. Population Sciences Research Program (816)
  6. Survivorship Research (716)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (223)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (161)
  6. William Jarnagin (157)

More People

Years
  1. 2025 (96)
  2. 2024 (256)
  3. 2023 (234)
  4. 2022 (264)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (762)
  2. European Urology (570)
  3. Lancet Oncology (394)
  4. Urology (388)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (272)

More Publications

Results (5503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): Primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
    Journal Article

    Smit, E. F.; Felip, E.; Uprety, D.; Nagasaka, M.; Nakagawa, K.; Paz-Ares Rodríguez, L.; Pacheco, J. M.; Li, B. T.; Planchard, D.; Baik, C.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Clearing the smoke: Underreporting of smoking status in Food and Drug Administration-approved bladder cancer therapeutic trials
    Editorial

    Kay, H.; Matulewicz, R. S.; Bjurlin, M. A.
    Journal of Urology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
    Journal Article

    Delforge, M.; Patel, K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T. S.; Arnulf, B.; Cavo, M.; Nooka, A.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
    Review

    Browne, I. M.; André, F.; Chandarlapaty, S.; Carey, L. A.; Turner, N. C.
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Incidence, predictors, and impact of hospital readmission after revascularization for left main coronary disease
    Journal Article

    Kosmidou, I.; Shahim, B.; Dressler, O.; Redfors, B.; Morice, M. C.; Puskas, J. D.; Kandzari, D. E.; Karmpaliotis, D.; Brown, W. M. 3rd; Lembo, N. J.; more...
    Journal of the American College of Cardiology (2024)

    Fulltext@MSK | Save
  • Unmet sexual health resource needs and preferences for interventions to address these needs among female partners of patients with prostate cancer
    Journal Article

    Gupta, N.; Zebib, L.; Wittmann, D.; Nelson, C. J.; Salter, C. A.; Mulhall, J. P.; Byrne, N.; Nolasco, T. S.; Schofield, E.; Loeb, S.
    Urology (2024)

    Fulltext@MSK | Save
  • Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): A phase 3, multicentre, open-label trial
    Journal Article

    Mahadeo, K. M.; Baiocchi, R.; Beitinjaneh, A.; Chaganti, S.; Choquet, S.; Dierickx, D.; Dinavahi, R.; Duan, X.; Gamelin, L.; Ghobadi, A.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Reply
    Correspondence

    Chen, E.; Deshane, A.; Choi, S.; Bhatt, A.
    Journal of the American College of Radiology (2024)

    Fulltext@MSK | Save
  • Transsternal core biopsy of anterior mediastinal masses: Safe and effective
    Meeting Abstract

    Deipolyi, A.; Kister, N.; Covey, A.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Abstract of the Year: Breast cancer recurrence after cryoablation
    Meeting Abstract

    Jean, J.; Bryce, Y.
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save